|
Volumn 520, Issue 1-3, 2002, Pages 161-166
|
Human small cell lung cancer NYH cells resistant to the bisdioxopiperazine ICRF-187 exhibit a functional dominant Tyr165Ser mutation in the Walker A ATP binding site of topoisomerase IIα
|
Author keywords
Bisdioxopiperazine; Drug resistance; Mutation; Topoisomerase II
|
Indexed keywords
ADENOSINE TRIPHOSPHATE;
DNA TOPOISOMERASE (ATP HYDROLYSING);
KINETOPLAST DNA;
RAZOXANE;
ARTICLE;
BINDING SITE;
CATALYSIS;
CONTROLLED STUDY;
DRUG SENSITIVITY;
ENZYME ACTIVITY;
ENZYME ASSAY;
ENZYME PURIFICATION;
HUMAN;
HUMAN CELL;
HYDROLYSIS;
LUNG SMALL CELL CANCER;
PHARMACOPHORE;
PLASMID;
POINT MUTATION;
PRIORITY JOURNAL;
WILD TYPE;
YEAST;
ADENOSINE TRIPHOSPHATE;
AMINO ACID SUBSTITUTION;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC AGENTS;
BINDING SITES;
CARCINOMA, SMALL CELL;
CELL DIVISION;
DNA TOPOISOMERASES, TYPE II, EUKARYOTIC;
DNA-BINDING PROTEINS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG RESISTANCE, FUNGAL;
DRUG RESISTANCE, NEOPLASM;
GENOTYPE;
HUMANS;
LUNG NEOPLASMS;
MUTATION;
PROTEIN BINDING;
RAZOXANE;
SACCHAROMYCES CEREVISIAE;
TRANSFORMATION, GENETIC;
TUMOR CELLS, CULTURED;
STAPHYLOCOCCUS PHAGE 187;
|
EID: 0037024363
PISSN: 00145793
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-5793(02)02805-3 Document Type: Article |
Times cited : (23)
|
References (20)
|